title: Regarding "Increased prefrontal and hippocampal glutamate concentration in schizophrenia: evidence from a magnetic resonance spectroscopy study".
authors.forename: Jean
authors.initials: J
authors.lastname: Théberge
authors.forename: J Eric
authors.initials: JE
authors.lastname: Jensen
authors.forename: Laura M
authors.initials: LM
authors.lastname: Rowland
mesh_terms: D001224:Aspartic Acid / Q000031:analogs & derivatives / Q000378:metabolism; D002794:Choline / Q000378:metabolism; D003401:Creatine / Q000378:metabolism; D004292:Dominance, Cerebral / Q000502:physiology; D018698:Glutamic Acid / Q000378:metabolism*; D006179:Gyrus Cinguli / Q000503:physiopathology; D006624:Hippocampus / Q000503:physiopathology*; D006801:Humans; D009682:Magnetic Resonance Spectroscopy; D010725:Phosphocreatine / Q000378:metabolism; D017397:Prefrontal Cortex / Q000503:physiopathology*; D012016:Reference Values; D012559:Schizophrenia / Q000503:physiopathology*; D013788:Thalamus / Q000503:physiopathology
chemical_list: D010725:Phosphocreatine; D001224:Aspartic Acid; D018698:Glutamic Acid; C000179:N-acetylaspartate; D003401:Creatine; D002794:Choline